Drugs / autologous neuroinduced MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02497443 | Apr 2011 → Dec 2017 | epilepsy | Ministry of Public Health, Republic of Belarus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous neuroinduced MSCs | “The final autologous cultured MSCs (0.7 -1.4 x 106 cells/kg of weigh) and autologous neuroinduced MSCs (0.04 - 0.1 x 106 cells/kg of weigh) were used for intravenous...” NCT02497443 ↗ |
| Known as | neuroinduced MSCs | “The final autologous cultured MSCs (0.7 -1.4 x 106 cells/kg of weigh) and autologous neuroinduced MSCs (0.04 - 0.1 x 106 cells/kg of weigh) were used for intravenous...” NCT02497443 ↗ |
| Route | Intrathecal | “a single intrathecal injection of neurally induced autologous MSC” PMID 28500900 ↗ May 2017 |